Another report revealed that disruption of cholesterol biosynthesis or statin treatment enhanced TGF-β1 expression, promoting EMT and a mesenchymal phenotype in pancreatic cancer (Gabitova-Cornell et al., 2020). This evidence concerns the gene TGFB1 and pancreatic neoplasm.